Published in Gene Therapy Weekly, May 1st, 2003
"Intraocular delivery of a variety of neurotrophic factors has been widely investigated as a potential treatment for retinal dystrophy (RD). The most commonly studied factor, ciliary neurotrophic factor (CNTF), has been shown to preserve retinal morphology and to promote cell survival in a variety of models of RD," wrote F.C. Schlichtenbrede and colleagues.
They used adeno-associated virus (AAV)-mediated gene delivery in one group of Prph2(Rd2/Rd2) mice and AAV-mediated gene delivery...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.